Intellia Therapeutics: gene editing and investment challenges
The current state of Intellia Therapeutics
Intellia Therapeutics $NTLA is a biotechnology company that specializes in gene editing and represents an innovative approach to treating rare genetic diseases. Although it is a company with great potential, it currently has no approved products. Unlike traditional investment... Read more
Oh, my goodness, that looks crazy. I'm definitely not going for it.